Article Details
Retrieved on: 2024-05-13 12:33:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
Delix Therapeutics' novel compound DLX-001, a neuroplastogen, has shown potential as an antidepressant that promotes neuroplasticity without the adverse effects commonly associated with dissociative drugs or hallucinogens. Trial results indicate safety, tolerability, and brain activity.
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here